Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2022 After Market Close on September 8, 2021
01 sept. 2021 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Global Biopharmaceutical Contract Manufacturing Market (2020 to 2030) - by Type of Product, Scale of Operations, Expression System, Company Size, Biologics and Key Geographical Regions
10 août 2021 04h58 HE
|
Research and Markets
Dublin, Aug. 10, 2021 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Contract Manufacturing Market by Type of Product, Scale of Operations, Expression System, Company Size, Biologics and Key...
Global Single-use Bioprocessing Market Outlook and Forecast 2021-2026: High Uptake of Biopharmaceuticals & Biosimilars
06 avr. 2021 04h58 HE
|
Research and Markets
Dublin, April 06, 2021 (GLOBE NEWSWIRE) -- The "Single-use Bioprocessing Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. In-depth Analysis...
Insights on the Cell Line Development and Characterization Services Global Market to 2030 - Industry Trends and Forecasts
16 févr. 2021 04h53 HE
|
Research and Markets
Dublin, Feb. 16, 2021 (GLOBE NEWSWIRE) -- The "Cell Line Development and Characterization Services by Sources of Cell Lines/Expression Systems, Applications of Cell Lines, and Geography: Industry...
CherryCircle Software Offers Its QbDVision® Platform for Free for COVID-19 Treatment Development
13 mars 2020 07h00 HE
|
CherryCircle Software, Inc.
AUSTIN, Texas, March 13, 2020 (GLOBE NEWSWIRE) -- CherryCircle Software, Inc., an Austin, Texas-based software development company, announced today that it will provide its cloud-based QbDVision...
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2019 After Market Close on December 10, 2018
03 déc. 2018 08h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve...